Young people with a rare condition called Juvenile Idiopathic Arthritis (JIA) are taking part in clinical research to better understand the condition, including to find out why some children have more ...

Both types have an infectious cause in the ... International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.

Biologic therapy reduces TMJ inflammation in children with juvenile arthritis, according to a new study. Findings show ...

Methotrexate (MTX) is the widely agreed upon first-choice second-line agent to treat juvenile idiopathic arthritis (JIA), up to 75% of JIA patients in recent registries have used MTX at some time ...

Patients with JIA-associated uveitis who discontinued adalimumab had higher recurrence rates than those who continued the ...